<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02320773</url>
  </required_header>
  <id_info>
    <org_study_id>178-MA-1002</org_study_id>
    <nct_id>NCT02320773</nct_id>
  </id_info>
  <brief_title>A Prospective Non-interventional Study in Overactive Bladder (OAB) Patients Prescribed Betmiga® as Part of Routine Clinical Practice</brief_title>
  <acronym>BELIEVE</acronym>
  <official_title>Non-Interventional Study Assessing Quality of Life, Treatment Satisfaction, Resource Utilisation, and Persistence With Treatment in Overactive Bladder (OAB) Patients Prescribed Betmiga® - A Multicenter Non-interventional Post Authorisation Study (PAS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Astellas Pharma Europe Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Astellas Pharma Inc</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A study to understand the impact of Betmiga® on patients quality of life, satisfaction with
      treatment, how long patients remain on treatment, patterns of healthcare resource
      utilisation, and safety as prescribed by the physicians in routine clinical practice.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Single arm, hybrid model study, observing patients on Betmiga under conditions of routine
      clinical practice, with some element of retrospective data collection 2 years prior to
      enrolment of the study
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 25, 2014</start_date>
  <completion_date type="Actual">July 27, 2016</completion_date>
  <primary_completion_date type="Actual">July 27, 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in QoL based on the OAB-q subscales</measure>
    <time_frame>Baseline up to 12 months post-baseline</time_frame>
    <description>Quality of life (QoL) based on the Overactive bladder questionnaire (OAB-q) subscales</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in patient treatment satisfaction based on TS-VAS</measure>
    <time_frame>Baseline up to 12 months post-baseline</time_frame>
    <description>Based on Treatment Satisfaction Visual Analogue Scale (TS-VAS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in QoL based on the EQ-5D-5L subscales and WPAI:SHP</measure>
    <time_frame>Baseline up to 12 months post-baseline</time_frame>
    <description>QoL based on Work Productivity Activity Index:Specific Health Problem (WPAI:SHP) and EUROQOL 5-DIMENSIONS (EQ5D)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Summary of utilisation of healthcare resources related to the management of OAB</measure>
    <time_frame>From enrollment to end of study (up to 12 months)</time_frame>
    <description>Overactive bladder (OAB) healthcare resources are captured by the investigator and include: healthcare visits, medical interventions, number of incontinence pads used in last 7 days, invasive/surgical treatments of OAB symptoms and any other investigations of OAB (including clinical interpretation if available)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency summary of disease progression</measure>
    <time_frame>From enrollment to end of study (up to 12 months</time_frame>
    <description>Disease progression is defined by occurrence of invasive/surgical treatment of OAB symptoms during the study. Overactive Bladder (OAB) treatments include e.g. Botulinum toxin type A, Sacral Neural Stimulation (SNS), Percutaneous tibial nerve stimulation (PTNS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in incontinence status during the study</measure>
    <time_frame>Baseline up to 12 months post-baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety assessed by recording of AEs and ADRs during the study</measure>
    <time_frame>From enrollment to end of study (up to 12 months)</time_frame>
    <description>Adverse Events (AEs), Adverse Drug Reaction (ADR)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Summary of prescription status to assess treatment patterns and persistence with treatment</measure>
    <time_frame>Baseline up to 12 months post-baseline</time_frame>
    <description>This composite summary includes the following items:
Number and percentage of patients who switched treatment, and to what treatment they were switched.
Number and percentage of patients who stopped treatment and reasons associated with discontinuation.
Number of treatment days on current treatment.
Time from treatment initiation to discontinuation or switching to another treatment.
Time from treatment initiation to prescription of additional oral OAB treatment and reasons for combination treatment.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">863</enrollment>
  <condition>Urgency Incontinence</condition>
  <condition>Urinary Bladder Overactive</condition>
  <condition>Overactive Bladder</condition>
  <condition>Urologic Diseases</condition>
  <condition>Urinary Bladder Diseases</condition>
  <arm_group>
    <arm_group_label>1. OAB patients taking Betmiga®</arm_group_label>
    <description>OAB patients whose physician has made the decision to prescribe Betmiga® as part of routine clinical practice and who are about to start treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Betmiga®</intervention_name>
    <description>Oral</description>
    <arm_group_label>1. OAB patients taking Betmiga®</arm_group_label>
    <other_name>YM178</other_name>
    <other_name>Mirabegron</other_name>
    <other_name>Myrbetriq®</other_name>
    <other_name>Betanis®</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Secondary care centers
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who have been diagnosed with OAB symptoms at Visit 1 of this study. OAB is
             defined by the International Urogynecological Association (IUGA)/International
             Continence Society (ICS) 2010 joint report as urinary urgency, with or without urinary
             incontinence, usually with frequency and nocturia, with no proven infection or other
             obvious pathology.

          -  Patients whose physician has made the decision to prescribe Betmiga® as part of
             routine clinical practice and who are about to start treatment.

        Exclusion Criteria:

          -  Patients who are currently taking Betmiga®.

          -  Contraindication(s) as per the Betmiga® Summary of Product Characteristics (SPC).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Medical Affairs Europe</last_name>
    <role>Study Director</role>
    <affiliation>Astellas Pharma Europe Ltd.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Site CZ42009 UROMEDA s. r. o.</name>
      <address>
        <city>Brno</city>
        <zip>615 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42003 Fakultni nemocnice Brno-Bohunice</name>
      <address>
        <city>Brno</city>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42006 Hospital Kyjov</name>
      <address>
        <city>Kyjov</city>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42002 Fakultni nemocnice Kralovske Vinohrady</name>
      <address>
        <city>Praha 10</city>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42007 MEDICON a.s.</name>
      <address>
        <city>Praha 4</city>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42008 Oblastni nemocnice Pribram</name>
      <address>
        <city>Příbram</city>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42004 Krajská nemocnice Tomáše Bati</name>
      <address>
        <city>Zlín</city>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site DK45003 Sygehus Vendsyssel, Frederikshavn</name>
      <address>
        <city>Frederikshavn</city>
        <zip>9900</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site DK45004 Regionshospitalet Herning</name>
      <address>
        <city>Herning</city>
        <zip>7440</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site GR30002 University Hospital of Crete</name>
      <address>
        <city>Heraklion</city>
        <state>Crete</state>
        <zip>71110</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site GR30009 PGH Laiko</name>
      <address>
        <city>Athens</city>
        <zip>11527</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site GR30001 General Hospital of Athens &quot;Alexandra&quot;</name>
      <address>
        <city>Athens</city>
        <zip>11528</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site GR30007 Sismanoglio General Hospital</name>
      <address>
        <city>Athens</city>
        <zip>151 26</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site GR30011 General Hospital of Heraklion 'Venizelio-Pananio'</name>
      <address>
        <city>Heraklion</city>
        <zip>71409</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site GR30008 University Hospital of Ioannina</name>
      <address>
        <city>Ioannina</city>
        <zip>45445</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site GR30013 University Hospital of Ioannina</name>
      <address>
        <city>Ioannina</city>
        <zip>45500</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site GR30005 University Hospital of Larissa</name>
      <address>
        <city>Larisa</city>
        <zip>41110</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site GR30003 University Hospital of Patras</name>
      <address>
        <city>Patras</city>
        <zip>26504</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site GR30006 Papageorgiou General Hospital</name>
      <address>
        <city>Thessaloniki</city>
        <zip>56403</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site GR30012 Papageorgiou General Hospital of Thessaloniki</name>
      <address>
        <city>Thessaloniki</city>
        <zip>56403</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site IE35304 Midland Regional Hospital</name>
      <address>
        <city>Mullingar</city>
        <state>Co. Westmeath</state>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site IE35302 Coombe Hospital</name>
      <address>
        <city>Dublin 8</city>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site IE35303 Kerry General Hospital</name>
      <address>
        <city>Kerry</city>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site SK42101 Univerzitná nemocnica Bratislava - Kramáre</name>
      <address>
        <city>Bratislava 3</city>
        <zip>833 05</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site SK42106 UROCENTRUM LEVICE, s.r.o.</name>
      <address>
        <city>Levice</city>
        <zip>934 01,</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site SK42102 UROAMB, s.r.o.</name>
      <address>
        <city>Liptovský Mikuláš</city>
        <zip>03101</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site SK42104 Urologicka ambulancia, Miramed, sro</name>
      <address>
        <city>Rimavská Sobota</city>
        <zip>979 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site SK42107 Private Urological Care Center</name>
      <address>
        <city>Trenčín</city>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site SK42103 CMFF, sro</name>
      <address>
        <city>Vranov Nad Topľou</city>
        <zip>093 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site SK42105 ProCare Ziar nad Hronom</name>
      <address>
        <city>Žiar Nad Hronom</city>
        <zip>965 63</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site ES34005 Corporació Sanitaria Parc Taulí</name>
      <address>
        <city>Sabadell</city>
        <state>Barcelona</state>
        <zip>08208</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site ES34012 H. de Mendaro</name>
      <address>
        <city>Mendaro</city>
        <state>Guipuzcoa</state>
        <zip>20850</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site ES34015 Centro Médico Teknon</name>
      <address>
        <city>Barcelona</city>
        <zip>08022</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site ES34007 Hospital Universitario Vall D'Hebron</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site ES34017 Hospital de Mollet</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site ES34020 Hospital Universitario Basurto</name>
      <address>
        <city>Bilbao</city>
        <zip>48013</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site ES34009 Hospital Comarcal Santiago Apostol</name>
      <address>
        <city>Burgos</city>
        <zip>09200</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site ES34019 Hospital Universitario Lucus Augusti</name>
      <address>
        <city>Lugo</city>
        <zip>27003</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site ES34021 H. de Donostia</name>
      <address>
        <city>San Sebastian</city>
        <zip>20014</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site ES34011 Hospital del Rio Hortega</name>
      <address>
        <city>Valladolid</city>
        <zip>47011</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site ES34010 Policlínico de Vigo, S.A.-POVISA</name>
      <address>
        <city>Vigo</city>
        <zip>36211</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site SE46002 Urologkliniken Carlanderska</name>
      <address>
        <city>Göteborg</city>
        <zip>412 55</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site GB44005 Bradford Royal Infirmary</name>
      <address>
        <city>Bradford</city>
        <zip>BD9 6RJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site GB44011 Royal Blackburn Hospital</name>
      <address>
        <city>Burnley</city>
        <zip>BB10 2PQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site GB44016 Addenbrookes Hospital</name>
      <address>
        <city>Cambridge</city>
        <zip>CB2 0QQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site GB44009 St. Richards Hospital</name>
      <address>
        <city>Chichester</city>
        <zip>PO19 6SE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site GB44007 Northampton General Hospital</name>
      <address>
        <city>Cliftonville</city>
        <zip>NN1 5BD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site GB44015 University Hospital Coventry</name>
      <address>
        <city>Coventry</city>
        <zip>CV2 2DX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site GB44008 Croydon University Hospital</name>
      <address>
        <city>Croydon</city>
        <zip>CR7 7YE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site GB44003 Derriford Hospital</name>
      <address>
        <city>Derriford</city>
        <zip>PL6 8DH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site GB44019 Northern Devon Healthcare</name>
      <address>
        <city>Devon</city>
        <zip>EX31 4JB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site GB44001 Medway Hospital</name>
      <address>
        <city>Gillingham</city>
        <zip>ME5 7NY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site GB44004 Southern General Hospital</name>
      <address>
        <city>Glasgow</city>
        <zip>G51 4TF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site GB44013 Hinchingbrooke Hospital</name>
      <address>
        <city>Huntingdon</city>
        <zip>PE29 6NT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site GB44010 The Freeman Hospital</name>
      <address>
        <city>Newcastle upon Tyne</city>
        <zip>NE7 7DN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site GB44014 The Queen Elizabeth Hospital King's Lynn NHS Trust</name>
      <address>
        <city>Norfolk</city>
        <zip>PE30 4ET</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site GB44002 The Royal Berkshire Hospital</name>
      <address>
        <city>Reading</city>
        <zip>RG1 5AN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site GB44018 Salisbury District Hospital</name>
      <address>
        <city>Salisbury</city>
        <zip>SP2 8BJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site GB44017 Sunderland Royal University Hospital</name>
      <address>
        <city>Sunderland</city>
        <zip>SR4 7TP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site GB44006 New Cross Hospital</name>
      <address>
        <city>Wolverhampton</city>
        <zip>WV10 OQP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Czechia</country>
    <country>Denmark</country>
    <country>Greece</country>
    <country>Ireland</country>
    <country>Slovakia</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>United Kingdom</country>
  </location_countries>
  <removed_countries>
    <country>Czech Republic</country>
  </removed_countries>
  <link>
    <url>https://astellasclinicalstudyresults.com/study.aspx?ID=223</url>
    <description>Link to results on the Astellas Clinical Study Results website.</description>
  </link>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 17, 2014</study_first_submitted>
  <study_first_submitted_qc>December 16, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 19, 2014</study_first_posted>
  <last_update_submitted>September 8, 2017</last_update_submitted>
  <last_update_submitted_qc>September 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Overactive Bladder</keyword>
  <keyword>Quality of Life</keyword>
  <keyword>Betanis®</keyword>
  <keyword>Betmiga®</keyword>
  <keyword>Observational</keyword>
  <keyword>Myrbetriq®</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Bladder, Overactive</mesh_term>
    <mesh_term>Urologic Diseases</mesh_term>
    <mesh_term>Urinary Bladder Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mirabegron</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

